Rhein suppresses osteosarcoma progression via modulating the miR-328-3p/TCF7L2/FABP4 axis
Biochemical Pharmacology · 2025-11 · 241 · 117152
DOI: 10.1016/j.bcp.2025.117152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2025-11. Verfasst von Xin Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, Dalian Medical University,Dalian, Liaoning 116044, PR China. Hauptthemen laut MEDLINE: Osteosarcoma, MicroRNAs, Transcription Factor 7-Like 2 Protein, Fatty Acid-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Dalian Medical University.
Abstract (Originalsprache)
Rhein (RH), an anthraquinone compound extracted from the Chinese herb rhubarb, exerts antitumour effects on various cancers. However, the role and underlying molecular mechanisms of RH in osteosarcoma remain unknown. In this study, we observed that RH significantly inhibited osteosarcoma cell proliferation, migration, invasion and stemness in vitro while promoting death and curtailing tumourigenesis in vivo. Mechanistically, RH downregulated the expression of FABP4 in osteosarcoma cells. The induction of death by RH was augmented by FABP4 knockdown and diminished by FABP4 overexpression. Depletion of FABP4 suppressed osteosarcoma cell proliferation in vitro and in vivo. Then, we found that TCF7L2 was directly bound to the FABP4 promoter and facilitated its transcription. Downregulation of TCF7L2 inhibited FABP4 expression and enhanced the anticancer effects of RH in osteosarcoma. Additionally, our investigations revealed that RH significantly upregulated miR-328-3p expression, resulting in the downregulation of TCF7L2 protein levels in osteosarcoma cells. Our findings indicate that miR-328-3p/TCF7L2/FABP4 axis is vital for the anticancer effects of RH and may be a potential therapeutic agent for osteosarcoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital, Dalian Medical University,Dalian, Liaoning 116044, PR China.
- Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning 116044, PR China.
- College of Medical Laboratory, Dalian Medical University, Dalian 116044, PR China. Electronic address: weiw01@dmu.edu.cn.
- The Second Affiliated Hospital, Dalian Medical University,Dalian, Liaoning 116044, PR China. Electronic address: drzwz@163.com.
- The Second Affiliated Hospital, Dalian Medical University,Dalian, Liaoning 116044, PR China. Electronic address: 1773263909@qq.com.
- The Second Affiliated Hospital, Dalian Medical University,Dalian, Liaoning 116044, PR China. Electronic address: zhanglu_dalian@163.com.
Förderung
- Dalian Medical University
Zitieren
APA
Zhao, X., Wang, R., Xia, X., Han, C., Wei, W., Zhao, W., Ji, R., & Zhang, L. (2025). Rhein suppresses osteosarcoma progression via modulating the miR-328-3p/TCF7L2/FABP4 axis. Biochemical Pharmacology, 241, 117152. https://doi.org/10.1016/j.bcp.2025.117152
Vancouver
Zhao X, Wang R, Xia X, Han C, Wei W, Zhao W, et al. Rhein suppresses osteosarcoma progression via modulating the miR-328-3p/TCF7L2/FABP4 axis. Biochemical Pharmacology. 2025;241:117152. doi:10.1016/j.bcp.2025.117152
BibTeX
@article{Zhao2025,
author = {Zhao, Xin and Wang, Ruiheng and Xia, Xin and Han, Chuanchun and Wei, Wei and Zhao, Wenzhi and Ji, Renchen and Zhang, Lu},
title = {Rhein suppresses osteosarcoma progression via modulating the miR-328-3p/TCF7L2/FABP4 axis},
journal = {Biochemical Pharmacology},
year = {2025},
volume = {241},
pages = {117152},
doi = {10.1016/j.bcp.2025.117152}
}
EUVIMED